More Information
Treatment of ibuprofen intoxication with charcoal haemoperfusion in two dogs
Authors: Wolff EDS, Bandt C, Bolfer LPublication: New Zealand Veterinary Journal, Volume 68, Issue 4, pp 255-260, Jul 2020
Publisher: Taylor and Francis
Animal type: Dog
Article class: Clinical Communication
Abstract:
Case history: Two dogs presented separately to the Small Animal Hospital, University of Florida (Gainsville, FL, USA) for ingestion of ibuprofen. The first dog ingested 561.8 mg/kg ibuprofen in addition to paracetamol and caffeine and vomited prior to admission. This patient also received fluid therapy for 8 hours prior to charcoal haemoperfusion. The second dog ingested 500 mg/kg of ibuprofen and the owners induced vomiting with hydrogen peroxide prior to presentation. Due to the severity of clinical signs, both patients were treated with charcoal haemoperfusion.
Clinical findings: The concentrations of ibuprofen in the blood of the dogs prior to treatment were 478 and 301 mg/L. During the treatment ibuprofen concentrations were reduced by 95.8% and 45.5%, respectively, with no treatment side effects and minimal clinical signs after treatment.
Diagnosis: Toxicity due to ingestion of ibuprofen toxicity that was successfully treated with charcoal haemoperfusion.
Clinical relevance: In the cases described here minimal benefit was seen after 3 hours of treatment using one haemoperfusion cartridge. This is in contrast to a previously published report in which dogs were treated for 6 hours with two charcoal haemoperfusion cartridges. This suggests that one cartridge may be sufficient. The amount of ibuprofen ingested was not a reliable predictor of the concentration in blood at the initiation of treatment. Charcoal haemoperfusion is an effective means of reducing plasma concentrations of ibuprofen, however, its use may be limited by its cost and availability.
Keywords: Charcoal haemoperfusion, ibuprofen toxicity, haemodialysis, canine, LC-MS, high flux dialyser
Access to the full text of this article is available to members of:
- SciQuest - Complimentary Subscription
Login
Otherwise:
Register for an account